NanoCarrier signs license preferential negotiating rights agreement with AccuRna
Dec 4 (Reuters) - NanoCarrier Co Ltd <4571.T> ::Says it and AccuRna Inc entered into a preferential negotiating rights agreement on exclusive right to license of drug development based on co's gene delivery technology.Co will get payment from AccuRna according to the agreement.Co also plans to inject capital into AccuRna Inc .
Latest Key Developments inBiotechnology
- Cyclerion Therapeutics Files For Offering Of Up To 11.55 Mln Shares Of Common Stock By The Selling Stockholders
- Seres Therapeutics Says Board Appointed Marcus Chapman As Principal Financial And Accounting Officer
- Prothena Reports Results From The Phase 3 Vital Amyloidosis Study Of Neod001 In Al Amyloidosis
- Mainstay Medical Says Primary Endpoint Of Reactiv8-B Clinical Trial Was Not Achieved